News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novotech, Quintiles And Pharma Firms Debate Pros And Cons Of Outsourcing Clinical Trials Globally


10/19/2005 5:13:12 PM

DALLAS--(BUSINESS WIRE)--April 4, 2005--Novotech, Australia's leading contract research organization (CRO), today announced that Novotech CEO Alek Safarian will debate the pros and cons of outsourcing globally at the 14th Annual Partnership with CROs and other Outsourcing Providers (April 4-6 Dallas). Other panelists include executives from pharma firms, and Quintiles Transnational.

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES